This content is machine translated Immuno-oncological therapies CAR-T cell therapy for hematologic cancers Immunotherapies are now established pillars in the treatment of cancer. The principle of CAR-T cell therapy is that the body’s own T cells are programmed to destroy cancer cells through…
View Post 27 min This content is machine translated Uveal melanoma Development of a CAR T-cell therapy for uveal melanoma T cells that are endowed with tumor specificity through the expression of a chimeric antigen recept or (CAR) are becoming increasingly important. They are already increasingly being used in adoptive… CME-Test
View Post 27 min This content is machine translated Uveal melanoma Development of a CAR T-cell therapy for uveal melanoma T cells that are endowed with tumor specificity through the expression of a chimeric antigen recept or (CAR) are becoming increasingly important. They are already increasingly being used in adoptive… CME-Test
View Post 2 min This content is machine translated Aspergillosis and lung function Hope for newly developed therapeutic options Aspergillus fumigatus is a common mold that is relatively harmless if you have a good immune response. However, in people whose immune system is severely weakened – for example, after…
View Post 6 min This content is machine translated Multiple Myeloma CAR-T cells, autologous and allogeneic stem cell transplantation: Who is winning the race? Autologous stem cell transplantation is highly valued in the treatment of multiple myeloma. In recent decades, the use of allogeneic blood stem cell transplantation has also been tested, but despite…
View Post 6 min This content is machine translated CAR-T cell therapy Paving the way to success With the increasing clinical application of CAR-T cells, the practical aspects of therapy are a growing concern. Which patients should receive treatment using CAR-T cells outside of clinical trials? What…
View Post 12 min This content is machine translated Interview: Prof. Dr. med. Dr. sc. nat. Heinz Läubli Promoting collaboration – at all levels Recently, Prof. Dr. Dr. Heinz Läubli, Head Physician for Oncology at the University Hospital Basel, received this year’s Annemarie Karrasch Research Award of the Basel Research Foundation propatient. Läubli’s research…
View Post 6 min This content is machine translated CAR-T Cells Own immune cell as therapy With the rapid development of new therapeutic options in oncology, immunotherapy has a high priority. Thus, CAR T cells are also a promising approach to treat advanced cancers. In particular,…
View Post 3 min This content is machine translated Cancer medicine of the future Car-T cell therapy and its application in practice CAR-T cell technology is considered the latest achievement in cancer medicine. The first approvals in Europe took place in mid-2018 – Switzerland followed at the end of 2018. Currently, the…
View Post 3 min This content is machine translated Immunotherapy Wider use for CAR-T cell treatment possible in the future? CAR-T cells have solved a central problem in cancer therapy – they make tumors visible again to the immune system. The initial successes in B-cell lymphomas are now attracting a…
View Post 10 min This content is machine translated Developments in the field of acute leukemias The beginning of a new era in therapy Therapy for AML and ALL is on the move. In the future, it will be much more differentiated. Some new options have already been approved, while others are in development…
